Related Experiment Video
Updated: Aug 12, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
LINC01278 Induces Autophagy to Inhibit Tumour Progression by Suppressing the mTOR Signalling Pathway
Bo Liu1,2, Xueting Yao3, Chaoyang Zhang4
1State Key Laboratory of Ophthalmology, Optometry, And Vision Science, Wenzhou Medical University, Wenzhou, China.
Abstract:
Uveal melanoma (UM) is an aggressive intraocular malignant tumour that is closely related to autophagic dysfunction. We aimed to identify autophagy-related long noncoding RNAs (lncRNAs) to elucidate the molecular mechanism of UM. Here, we show that LINC01278 is a new potential biomarker with clinical prognostic value in UM through bioinformatics analysis. Application of an autophagy inhibitor (3-MA) and an autophagy agonist (MG-132) indicated that LINC01278 can inhibit UM cell proliferation, migration, and invasion by inducing autophagy. A xenograft nude mouse model was used to examine the tumorigenesis of UM cells in vivo. Mechanistically, LINC01278 can inhibit the mTOR signalling pathway to activate autophagy, as shown by experiments with an mTOR agonist (MHY1485) and mTOR inhibitor (rapamycin) treatment. Our findings indicate that LINC01278 functions as a tumour suppressor by inhibiting the mTOR signalling pathway to induce autophagy. Targeting the LINC01278-mTOR axis might be a novel and promising therapeutic approach for UM.
Insights
LINC01278, a long noncoding RNA, suppresses uveal melanoma (UM) by activating autophagy via the mTOR pathway. This discovery offers a potential new therapeutic target for this aggressive eye cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Uveal melanoma (UM) is an aggressive intraocular tumor linked to impaired autophagy.
- Identifying novel molecular mechanisms and biomarkers is crucial for UM treatment.
Purpose of the Study:
- To identify autophagy-related long noncoding RNAs (lncRNAs) involved in UM.
- To elucidate the molecular mechanism of LINC01278 in UM progression.
Main Methods:
- Bioinformatics analysis to identify potential lncRNA biomarkers.
- In vitro experiments using autophagy inhibitors/agonists (3-MA, MG-132) to assess LINC01278 function.
- In vivo studies using a xenograft nude mouse model.
- Experiments with mTOR pathway modulators (MHY1485, rapamycin).
Main Results:
- LINC01278 was identified as a potential prognostic biomarker for UM.
- LINC01278 inhibits UM cell proliferation, migration, and invasion by inducing autophagy.
- LINC01278 suppresses tumor growth in vivo.
- LINC01278 activates autophagy by inhibiting the mTOR signaling pathway.
Conclusions:
- LINC01278 acts as a tumor suppressor in UM by inducing autophagy through mTOR pathway inhibition.
- Targeting the LINC01278-mTOR axis presents a promising therapeutic strategy for UM.
More Related Videos
09:10siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
11:39Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry
Published on: July 21, 2017
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...